Cargando…

Triple-Negative Breast Cancer: A Review of Conventional and Advanced Therapeutic Strategies

Triple-negative breast cancer (TNBC) cells are deficient in estrogen, progesterone and ERBB2 receptor expression, presenting a particularly challenging therapeutic target due to their highly invasive nature and relatively low response to therapeutics. There is an absence of specific treatment strate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Medina, Mauricio A., Oza, Goldie, Sharma, Ashutosh, Arriaga, L.G., Hernández Hernández, José Manuel, Rotello, Vincent M., Ramirez, Jose Tapia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7143295/ https://www.ncbi.nlm.nih.gov/pubmed/32245065 http://dx.doi.org/10.3390/ijerph17062078

Ejemplares similares

Synthesis, Characterization and Magnetic Hyperthermia of Monodispersed Cobalt Ferrite Nanoparticles for Cancer Therapeutics
por: Medina, Mauricio A., et al.
Publicado: (2020)

Identification of Transferrin Receptor 1 (TfR1) Overexpressed in Lung Cancer Cells, and Internalization of Magnetic Au-CoFe(2)O(4) Core-Shell Nanoparticles Functionalized with Its Ligand in a Cellular Model of Small Cell Lung Cancer (SCLC)
por: Villalobos-Manzo, Rocío, et al.
Publicado: (2022)

Early Triple Negative Breast Cancer: Conventional Treatment and Emerging Therapeutic Landscapes
por: Diana, Anna, et al.
Publicado: (2020)

Targeted Therapeutic Strategies for Triple-Negative Breast Cancer
por: Li, Ying, et al.
Publicado: (2021)

Biorecognition Engineering Technologies for Cancer Diagnosis: A Systematic Literature Review of Non-Conventional and Plausible Sensor Development Methods
por: Mayoral-Peña, Kalaumari, et al.
Publicado: (2022)

Therapeutic Strategies for Metastatic Triple-Negative Breast Cancers: From Negative to Positive
por: Nandini, Dey, et al.
Publicado: (2021)

Novel therapeutic strategies for patients with triple-negative breast cancer
por: Zhang, Jun-Fei, et al.
Publicado: (2016)

Novel therapeutic strategies in the treatment of triple-negative breast cancer
por: Oualla, Karima, et al.
Publicado: (2017)

Recent advances in therapeutic strategies for triple-negative breast cancer
por: Li, Yun, et al.
Publicado: (2022)

Optical Detection of Cancer Cells Using Lab-on-a-Chip
por: García-Hernández, Luis Abraham, et al.
Publicado: (2023)

Camphor-mediated synthesis of carbon nanoparticles, graphitic shell encapsulated carbon nanocubes and carbon dots for bioimaging
por: Oza, Goldie, et al.
Publicado: (2016)

The interaction between RE1-silencing transcription factor (REST) and heat shock protein 90 as new therapeutic target against Huntington’s disease
por: Orozco-Díaz, Raúl, et al.
Publicado: (2019)

Organic chemistry meets polymers, nanoscience, therapeutics and diagnostics
por: Rotello, Vincent M
Publicado: (2016)

Combined drug therapeutic strategies for the effective treatment of Triple Negative Breast Cancer
por: Chalakur-Ramireddy, Naveen K.R., et al.
Publicado: (2018)

Revealing targeted therapeutic opportunities in triple-negative breast cancers: A new strategy
por: Poage, Graham M, et al.
Publicado: (2013)

Current Therapeutic Strategies for Metastatic Triple-Negative Breast Cancer: From Pharmacists’ Perspective
por: Li, Shuanghe, et al.
Publicado: (2022)

Photoelectrocatalytic activity of silicon nanowires decorated with electroless copper nanoparticles and graphene oxide using a plasma jet for removal of methyl orange under visible light
por: Hernández Rodríguez, Carlos, et al.
Publicado: (2023)

Plasmonic/Magnetic Multifunctional nanoplatform for Cancer Theranostics
por: Ravichandran, M., et al.
Publicado: (2016)

Therapeutic potential of Fingolimod in triple negative breast cancer preclinical models
por: Rupp, Tristan, et al.
Publicado: (2020)

Advances and Applications of Water Phytoremediation: A Potential Biotechnological Approach for the Treatment of Heavy Metals from Contaminated Water
por: Delgado-González, Cristián Raziel, et al.
Publicado: (2021)

EGFR conjunct FSCN1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer
por: Wang, Chao-Qun, et al.
Publicado: (2017)

Pharmacokinetics and Pharmacodynamics of Conventional-Dose vs Triple-Dose Oseltamivir in Severely Immunocompromised Children With Influenza
por: Bautista, Francisco, et al.
Publicado: (2019)

Algebraic Structure of Adjoint Triples Generating a Weak Negation on the Unit Interval
por: Cornejo, M. Eugenia, et al.
Publicado: (2020)

Early-stage Triple-negative Breast Cancer: Time to Optimize Personalized Strategies
por: Abuhadra, Nour, et al.
Publicado: (2022)

Triple-Negative Breast Cancer: Adjuvant Therapeutic Options
por: Gucalp, Ayca, et al.
Publicado: (2011)

Therapeutic landscape in mutational triple negative breast cancer
por: Shi, Yaqin, et al.
Publicado: (2018)

Chk1 Inhibition as a novel therapeutic strategy for treating triple-negative breast and ovarian cancers
por: Bryant, Christopher, et al.
Publicado: (2014)

Combined Inhibition of ATR and WEE1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer
por: Jin, Juan, et al.
Publicado: (2018)

PP2A as the Main Node of Therapeutic Strategies and Resistance Reversal in Triple-Negative Breast Cancer
por: Zhao, Henan, et al.
Publicado: (2017)

Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer
por: Xu, Jiangsheng, et al.
Publicado: (2019)

Synthesis and Biodegradation Test of a New Polyether Polyurethane Foam Produced from PEG 400, (L)-Lysine Ethyl Ester Diisocyanate (L-LDI) and Bis-hydroxymethyl Furan (BHMF)
por: Olivito, Fabrizio, et al.
Publicado: (2023)

Triple-negative breast cancer: current treatment strategies and factors of negative prognosis
por: Baranova, Anna, et al.
Publicado: (2022)

Tumor penetrating peptides inhibiting MYC as a potent targeted therapeutic strategy for triple-negative breast cancers
por: Wang, Edina, et al.
Publicado: (2018)

CAPER as a therapeutic target for triple negative breast cancer
por: Campbell, Mallory C., et al.
Publicado: (2018)

Emerging Therapeutic Drugs in Metastatic Triple-Negative Breast Cancer
por: Cipriano, Élia, et al.
Publicado: (2021)

Molecular Targets and Promising Therapeutics of Triple-Negative Breast Cancer
por: Ryu, Won-Ji, et al.
Publicado: (2021)

Pathogenesis and Potential Therapeutic Targets for Triple-Negative Breast Cancer
por: Li, Chia-Jung, et al.
Publicado: (2021)

On the Therapeutic Potential of ERK4 in Triple-Negative Breast Cancer
por: Boudghene-Stambouli, Fadia, et al.
Publicado: (2022)

Ferroptosis and triple-negative breast cancer: Potential therapeutic targets
por: Xu, Na, et al.
Publicado: (2022)

Update on triple-negative breast cancer: prognosis and management strategies
por: Brouckaert, Olivier, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_0o06097n3oipvo1l157e6fan24